USANA Health Sciences Stock Rating Reaffirmed by Canaccord Genuity (USNA)

0
Rate this News
top-5-australian-business-directories-free-listing

Canaccord Genuity reaffirmed their hold rating on shares of USANA Health Sciences (NASDAQ:USNA) in a report issued on Thursday morning, Market Beat.comreports. Canaccord Genuity currently has a $131.00 target price on the stock, down from their prior target price of $136.00.

USANA Health Sciences (NASDAQ:USNA) traded up 0.62% during trading on Thursday, hitting $123.66. The stock had a trading volume of 47,137 shares. The company has a 50-day moving average price of $135.16 and a 200-day moving average price of $133.94. USANA Health Sciences has a 52-week low of $82.23 and a 52-week high of $176.88. The company has a market cap of $1.58 billion and a price-to-earnings ratio of 18.85.

USANA Health Sciences (NASDAQ:USNA) last announced its earnings results on Tuesday, August 4th. The company reported $1.92 earnings per share for the quarter, beating analysts’ consensus estimates of $1.60 by $0.32. During the same quarter in the prior year, the firm posted $1.36 earnings per share. The company had revenue of $233.20 million for the quarter, compared to analysts’ expectations of $211.86 million. USANA Health Sciences’s quarterly revenue was up 23.8% on a year-over-year basis. Equities research analysts forecast that USANA Health Sciences will post $7.16 EPS for the current year.

A number of other equities research analysts have also weighed in on the stock.Zacks upgraded USANA Health Sciences from a hold rating to a strong-buy rating and set a $167.00 price objective for the company in a research note on Tuesday, August 25th. Pivotal Research upgraded USANA Health Sciences from a hold rating to a buy rating and increased their price target for the stock from $135.00 to $200.00 in a research note on Wednesday, August 5th. Finally, DA Davidson downgraded shares of USANA Health Sciences from a buy rating to a neutral rating and increased their price objective for the company from $165.00 to $180.00 in a report on Thursday, August 6th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The stock has a consensus rating of Buy and a consensus target price of $163.80.

10/26/2015 |

Leave a Reply

Copyright © 2017, MLM Online | No.1 MLM Classified

Skip to toolbar